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Genomewide linkage analysis has been extremely successful at identification of the genetic variation underlying
single-gene disorders. However, linkage analysis has been less successful for common human diseases and other
complex traits in which multiple genetic and environmental factors interact to influence disease risk.We hypothesized
that a highly heritable complex trait, in which the contribution of environmental factors was relatively limited,
might be more amenable to linkage analysis. We therefore chose to study stature (adult height), for which heritability
is ∼75%–90% (Phillips and Matheny 1990; Carmichael and McGue 1995; Preece 1996; Silventoinen et al. 2000).
We reanalyzed genomewide scans from four populations for which genotype and height data were available, using
a variance-components method implemented in GENEHUNTER 2.0 (Pratt et al. 2000). The populations consisted
of 408 individuals in 58 families from the Botnia region of Finland, 753 individuals in 183 families from other
parts of Finland, 746 individuals in 179 families from Southern Sweden, and 420 individuals in 63 families from
the Saguenay-Lac-St.-Jean region of Quebec. Four regions showed evidence of linkage to stature: 6q24-25,multipoint
LOD score 3.85 at marker D6S1007 in Botnia (genomewide ), 7q31.3-36 (LOD 3.40 at marker D7S2195P ! .06
in Sweden, ), 12p11.2-q14 (LOD 3.35 at markers D12S10990-D12S398 in Finland, ) and 13q32-P ! .02 P ! .05
33 (LOD 3.56 at markers D13S779-D13S797 in Finland, ). In a companion article (Perola et al. 2001 [inP ! .05
this issue]), strong supporting evidence is obtained for linkage to the region on chromosome 7. These studies suggest
that highly heritable complex traits such as stature may be genetically tractable and provide insight into the genetic
architecture of complex traits.
Introduction
Most common diseases are complex genetic traits: not
only do multiple genetic loci contribute to susceptibility,
but environmental factors also play a major role in de-
termining risk. Understanding how genetic variation in-
fluences human complex-trait variation is thus vital to
understanding common disease. Genomewide linkage
analysis has been used to try to identify the genetic de-
terminants for many common diseases and complex
traits. This approach has the advantage of being a ge-
nomewide search for genetic factors that does not re-
quire a priori knowledge of the underlying biology or
risk alleles. However, linkage analysis thus far has had
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limited success for common disease. Specifically, most
studies have failed to generate significant evidence of
linkage, and the few regions with significant results have
proven difficult to replicate.
Several factors explain the limited success of linkage
studies for human complex traits. By definition,multiple
genetic alleles contribute to complex traits, and linkage
analysis has somewhat limited power for finding genes
of modest effect (Risch and Merikangas 1996). Also,
environmental variables often significantly affect phe-
notype and obscure genetic effects, which is reflected in
lower heritability. The power of linkage analysis is es-
sentially proportional to the square of heritability (see,
e.g., Lander and Botstein 1989; Sham et al. 2000), so
significant contributions by environmental influences
can severely limit power. Furthermore, phenotype as-
signment is often ambiguous or uncertain for many
common diseases and complex traits. For example,
individuals “unaffected” with a late-onset disease may
later convert to affected status; affected individuals may
also be classified incorrectly, as a result of phenocopy.
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Finally, for quantitative traits, measurement error or
intraindividual variation may degrade the accuracy of
phenotype measurement, contributing to nongenetic
sources of variance and reducing heritability.
We propose that stature is an example of a complex
trait in which some of these problems are minimized.
Estimates of heritability range from 76% to 90%, but
heritability is generally estimated to be 80% (Phillips
and Matheny 1990; Carmichael and McGue 1995;
Preece 1996; Silventoinen et al. 2000). In addition, stat-
ure is easily, reliably, and accurately measured, reducing
phenotypic uncertainty. Finally, it is inexpensive and
routine to measure stature in large populations. Of
course, it is impossible to know in advance how much
any single locus contributes to a complex trait; if stature
were significantly more polygenic than other complex
traits, these advantages would be partially or completely
offset by the increased difficulty of detecting loci with
more-modest genetic effects.
The genetics of stature have been studied at least since
1903, when measurements of height in families sug-
gested a high heritability (Pearson and Lee 1903). These
studies also revealed that adult height follows a normal
distribution, suggesting that multiple factors interact to
affect stature, perhaps in an additive fashion. Although
changing environmental influences, such as improved
nutrition, have led to a progressive increase in height
(“secular trend”), the genetic contribution to variation
in height is still discernible even where poor nutrition
is widespread—as in Gambia (Jepson et al. 1994)—and
heritability is high in both old and young cohorts (Car-
michael and McGue 1995; Silventoinen et al. 2000).
To our knowledge, no genomewide linkage studies of
stature have previously been published. One focused
study, using sib-pairs in Pima Indians, identified a region
of suggestive linkage on chromosome 20 ( ;Pp .0001
Thompson et al. 1995). Also, variation in five genes has
been reported to be associated with variation in height:
DRD2 (MIM 126450), encoding the dopamine D2 re-
ceptor (Miyake et al. 1999); VDR (MIM 601769), en-
coding the vitamin D receptor (Minamitani et al. 1998);
COL1A1 (MIM 120150), encoding collagen type I,
alpha 1 (Garnero et al. 1998); ESR1 (MIM 133430),
encoding the estrogen receptor, alpha (Lorentzon et al.
1999); and LHB (MIM 152780), encoding luteinizing
hormone (Raivio et al. 1996). We are unaware of con-
firmation of any of these associations or of the linkage
to chromosome 20. Thus, stature appears to be an ex-
cellent model complex trait, and, as yet, little is known
about its underlying genetics. In addition, stature is of
clinical interest, as many visits to pediatric endocrine
programs are related to short stature, and treatment
with growth hormone represents a significant portion
of pharmaceutical expenditures for children. Variation
in height has also been associated with variation in risk
of prostate cancer and coronary artery disease (possibly
through common hormonally mediated effects—see
Giovannucci et al. 1997; Hebert et al. 1997; Forsen et
al. 2000), as well as hip fracture (possibly caused by
greater impact velocity—see Hemenway et al. 1994,
1995), suggesting that some variants affecting stature
might also affect risk of these diseases. For these rea-
sons, we set out to identify regions of linkage to stature.
We used genomewide scans in four populations for
which genotyping, height, age, and gender data were
available. We analyzed these populations using a vari-
ance-components method (Pratt et al. 2000), using stat-
ure as a quantitative-trait locus (QTL), and showed that
four regions demonstrate strong evidence for linkage in
at least one of the four populations. In data presented
in an accompanying article by Perola et al. (Perola et
al. 2001 [in this issue]), one of these regions shows
strong evidence for linkage in an additional Finnish
sample, providing additional support for this region.
These initial results suggest that studying highly heri-
table traits such as stature may provide insight into the
genetic architecture of human complex genetic traits.
Subjects and Methods
Study Populations
In total, 2,327 individuals from 483 families were
studied (see table 1). Families had been previously iden-
tified by ascertaining probands either for type 2 diabetes
diagnosed by oral glucose-tolerance tests using WHO
criteria (families from Botnia, Sweden, Finland, and Sag-
uenay) or for angiographically proven coronary heart
disease (families from Saguenay). Full details of phen-
otyping and recruitment of patients and families have
been described elsewhere (Groop et al. 1996; Parker et
al. 2001) or will be described elsewhere, in studies de-
tailing genomewide linkage analysis for type 2 diabetes
or coronary heart disease (C.M.L, unpublished data;
D.G. and T.J.H., unpublished data; J. Engert, unpub-
lished data). There is no overlap between these samples
and those described in the accompanying article (Perola
et al. 2001 [in this issue]). Informed consent was ob-
tained from all individuals, and studies were approved
by the local institutional review boards and ethics com-
mittees. Blood was collected and genomic DNA was ex-
tracted from peripheral blood lymphocytes or from
whole blood. Height data was obtained by measurement
without shoes.
Mean family sizes were as follows: Botnia, 7.0 mem-
bers (range 2–18); Sweden, 4.2 members (range 2–13);
Finland, 4.1 members (range 2–11); Saguenay, 6.7 mem-
bers (range 3–15). The following number of families,
out of the total in each population, represented extended
pedigrees (not just single sibships or nuclear families):
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Table 1
Summary of Populations
POPULATION AND SEX
NO. OF INDIVIDUALS
MEAN  SD
AGE
(years )
MEAN  SD
HEIGHT
(cm)
NORMALITY TESTS
Genotyped Phenotyped Skewness Kurtosis Pa db
Botnia (58 families): .19 .85 1.99 .03
Female 207 185 5913.6 1616.0
Male 201 194 5914.2 1746.0
Finland (183 families): .19 1.86 1.99 .03
Female 429 388 6011.5 1606.3
Male 324 314 5712.1 1747.4
Sweden (179 families): .17 .02 1.99 .02
Female 374 334 6012.6 1646.0
Male 372 349 6011.8 1766.6
Saguenay–Lac-St.-Jean (6 families): .13 .23 1.99 .03
Female 220 161 558.2 1566.0
Male 200 186 568.8 1696.1
a P value for Kolmagoroff-Smirnoff test of normality, comparing the observed distribution of height Z scores with an ideal normal
distribution.
b d, maximal difference statistic for Kolmagoroff-Smirnoff test.
in Botnia, 47/58; in Sweden, 80/179; in Finland, 89/183;
and in Saguenay, 2/63. The number of founders geno-
typed were: in Botnia, 40; in Sweden, 75; in Finland,
62; and in Saguenay, 17.
Microsatellite Genotyping
For analysis of the Saguenay families, average inter-
marker spacing was 12 cM, and the markers used were
a modified version of the Cooperative Human Linkage
Centre (CHLC) Screening Set/version 6.0 that also in-
cluded Ge´ne´thon markers (similar to the set described
by Rioux et al. [2000]). Fluorescent genotyping was per-
formed as described elsewhere (Rioux et al. 2000). For
analysis of the Botnia families, the average intermarker
spacing was 6.5 cM, and markers were included from
Ge´ne´thon, the Genome Database (GDB), and the CHLC
(see Mahtani et al. 1996 and references therein). Fluo-
rescent and radioactive microsatellite genotyping was
performed as described previously (Mahtani et al. 1996).
For analysis of the Finland and Sweden families, average
intermarker spacing was 8.8 cM, and the marker map
was determined, using either CEPH pedigree data and
MultiMap (Matise et al. 1994) or information from the
GDB; fluorescent genotyping was performed using an
ABI 377XL DNA sequencer (Parker et al. 2001).
Analysis of Stature Data
Stature data was available for nearly all of the gen-
otyped individuals. To eliminate individuals from our
analysis who might still be growing, phenotype data was
discarded for men !23.5 years old and women !21.1
years old; nearly all individuals over these ages have
reached final adult height (Roche and Davila 1972). We
found that height among the adults was inversely cor-
related with age in both genders in all populations (slope
0.09–0.14 cm/year, –0.09). This finding is con-2r p 0.02
sistent either with a “secular trend” (in which younger
individuals are taller because of changing environmental
factors) or a loss of height with increasing age. We there-
fore adjusted the height data by regressing height against
age. After the initial regression against age, there was a
trend towards higher stature in individuals age 180 years
(data not shown). Accordingly, we eliminated data from
individuals in that age group (representing !3% of the
total data) and repeated the regression. We then calcu-
lated a Z score (standard deviations above or below the
mean) for height regressed against age, treating each
gender separately, so that data from both genders could
be combined. These Z scores were generated separately
for the Saguenay–Lac-St.-Jean data; the three Scandi-
navian populations were grouped for this purpose. For
calculation of sib-sib and parent-offspring correlations
within the Botnia population, 29 families were identified
in which Z scores were available for 2 siblings and
one parent. Where more individuals were available, 2
siblings and one parent from a family were chosen at
random.
These Z scores were used for linkage analysis using a
variance-components method implemented in GENE-
HUNTER 2.0 (Pratt et al. 2000). For each region of the
genome, this method estimates parameters to fit a model
in which total trait variance is divided into three com-
ponents: a QTL at the location being tested, other ge-
netic factors, and environmental factors. The method
uses nonparametric multipoint approaches developed
for GENEHUNTER (Kruglyak et al. 1996). The LOD
score at a location reflects the likelihood of the genotype
data being observed under the model of linkage (i.e.,
that a QTL is present at that location) relative to the
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Figure 1 Graph of the heritability of height Z scores in the
Botnia population. Each point on the X-axis represents a different
family; the families are arranged in increasing order of mean Z score.
For each family, the maximum (#), mean (thick line), and minimum
(•) height Z scores are shown. Heritability is reflected in the correlation
of Z scores within each family. In this population, a difference in Z
score of 1 represents ∼6 cm in height.
likelihood of the data being observed under the null
hypothesis (i.e., that there is no contribution to variance
by a QTL at the location).
The families in which we obtained positive results had
been ascertained for type 2 diabetes, and low birth
weight is a known risk factor for both type 2 diabetes
and short stature (Paz et al. 1993; Phillips 1998; Tuvemo
et al. 1999). Thus, we were concerned that, if height
were correlated with risk of type 2 diabetes, such a cor-
relation could skew our data. However, no such corre-
lation was observed between height and type 2 diabetes
(data not shown).
For estimates of significance for each population, phe-
notypic and pedigree data were retained, and genotypes
were randomly generated within sibships.Variance-com-
ponent genome-scan simulations were repeated 100
times for each population. Power simulations were also
conducted using a model with an additive QTL explain-
ing 20% of the variance of a normally distributed
phenotype with 80% heritability. Variance-component
simulations were repeated 500 times to calculate the
expected distribution of LOD scores, given such a QTL.
Results
Variance-Components Analysis of Stature in Four
Populations
To study the genetics of stature, we assembled data
for stature and age from individuals in four populations:
Finland, Southern Sweden, the Botnia region of Finland,
and the Saguenay–Lac-St.-Jean region of Quebec (table
1). DNA from these individuals was originally genoty-
ped for genomewide analysis of type 2 diabetes or cor-
onary heart disease (see Methods). We calculated height
Z scores from the stature data, correcting for gender and
age (see Methods for details). We used a variance-com-
ponents method because of increased power formapping
QTLs (Almasy and Blangero 1998; Pratt et al. 2000).
Importantly, variance-components methods assume nor-
mality of the underlying trait distribution, and certain
non-normal distributions can lead to an increased num-
ber of false positives (Allison et al. 1999). Height Z
scores were normally distributed in all populations—as
assessed by Kolmagoroff-Smirnoff tests, using STAT-
VIEW 5.0 (table 1) and x2 goodness-of-fit tests (data not
shown)—which is consistent with earlier studies of
height (Pearson and Lee 1903).
To minimize possible overall environmental variation,
we studied each population separately. The heritability
estimates were high in all populations (195% in Finland,
195% in Sweden, ∼80% in Botnia, and ∼70% in Sag-
uenay–Lac-St.-Jean; see fig. 1 for a graphic representa-
tion of the clustering of height within Botnia families).
To assess for the possible influence of shared environ-
ment on heritability, we attempted to compare the cor-
relation coefficients for parent-offspring pairs and sib
pairs. Since siblings share more environmental exposures
during linear growth than do parent-offspring pairs,
shared environmental influences on height should lead
to a tighter correlation between siblings than between
parents and offspring. This comparison could be made
for the Botnia population, where height data were avail-
able for at least two siblings and one parent in 29 of 58
families. Correlation coefficients for sib pairs and parent-
offspring pairs were essentially identical (0.535 vs.
0.541), consistent with the findings of Pearson and Lee
(1903) and suggesting that the high heritability of stature
in this population is not due to shared environment.
Varying degrees of assortative mating (positive corre-
lation coefficients between spouses) were observed in the
three populations where data were available for spouse
pairs ( in Botnia, 0.26 in Finland, and 0.03 in2r p 0.11
Sweden).
Multipoint variance-components analysis (fig. 2) re-
vealed four regions with multipoint LOD scores 13.3,
which is the approximate level of genomewide signifi-
cance for this method of analysis at (Pratt etap 0.05
al. 2000). The regions are: 6q24-25 (LOD 3.85 at
marker D6S1007 in Botnia), 7q31.3-36 (LOD 3.40 at
marker D7S2195 in Sweden), 12p11.2-q14 (LOD 3.35
at markers D12S10990-D12S398 in Finland), and
13q32-33 (LOD 3.56 at markers D13S779-D13S797 in
Finland). Multiple regions had LOD scores 11.0 (fig. 2;
table 2). In addition, five regions showed modest ev-
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idence for linkage in at least two populations (fig. 2;
table 2).
The regions with LOD scores 13.3 did not overlap
among the studies. Indeed, none of these regions were
independently replicated within our four populations.
However, concurrent studies described in the accom-
panying article (Perola et al. 2001 [in this issue]) also
show strong support for linkage to the chromosome 7
region (LOD 2.9; the solid bars in fig. 2 denote the two
regions with LOD 12.5 in the study by Perola et al.).
Thus, one of the four regions with strong evidence for
linkage in our studies has been replicated in another
population.
Previous analysis suggested that a LOD score of ∼3.3
corresponds to significant linkage for a single genome-
wide scan for this variance-components method (Pratt
et al. 2000). To assess the empiric significance of our
results, we performed simulations to determine thresh-
olds for significance within each population.We retained
phenotypic and pedigree information but randomly gen-
erated genotypes under the hypothesis of no linkage. The
empiric genomewide levels of significance for the most
prominent peaks in our study were: for 6q24-25, P !
; for 7q31-36, ; for 12p11-q14, ; and.06 P ! .02 P ! .05
for 13q32-33, . For reference, the empiric levelsP ! .05
of significance in the four populations associated with
different LOD scores are shown in table 3. These empiric
P values differ between populations because the samples
we studied vary considerably in terms of family size and
structure, total data set size, genotyping efficiency, and
percentage of parents/founders available for genotyping.
Since our study involved a set of four genomewide
scans, we evaluated the expected distribution of LOD
scores in such a set of scans under the hypothesis of no
linkage. From the permuted scans used to generate em-
piric levels of significance, we drew 100,000 sets of four
simulated scans, with each set containing one simulated
scan from each of the four populations. These simula-
tions indicated that the probability was small ( )P ! .01
of observing by chance a total of four or more regions
with LOD scores 13.0, suggesting that at least some of
the four regions observed to have LOD scores 13.3 rep-
resent regions of true linkage to stature. In this light, the
supporting evidence presented by Perola et al. for chro-
mosome 7 suggests that this region may harbor genetic
variation contributing to adult height (Perola et al. 2001
[in this issue]).
Assessment of Variable Linkage Results
One striking feature of our results is that regions with
the best evidence for linkage in a given population do
not show strong evidence for linkage in other popula-
tions. Two possible explanations of these findings are
the presence of population-specific effects on linkage and
the effect of statistical fluctuation (sampling variation)
on LOD scores in the presence of a real, but modest,
QTL. Population-specific effects are often invoked to
explain variable linkage results, and it is possible that
true differences between population (heterogeneity) ex-
plain some of the variability we observed. However, we
wanted to explore the effects of statistical fluctuation on
LOD scores in data sets such as ours, assuming the pres-
ence of a QTL that was consistent across all studied
populations.
To determine the expected distribution of LOD scores
arising from the presence of a QTL of moderate, but
significant, effect, we generated 400 simulated data sets
with the pedigree structure of our Swedish sample and
assumed an additive QTL explaining 20% of the total
variance. In the presence of such a QTL, the median
LOD score at that QTL was 1.40. In these power sim-
ulations, 15% of scans gave a LOD score 13.0, but 37%
of scans gave a LOD score !1.0, and fully 10% gave a
LOD score !0.1 (fig. 3). Indeed, many of these simulated
scans did not generate LOD scores near the “expected”
value of 1.40. This slightly counterintuitive result is con-
sistent with LOD scores following a x2 distribution,
which has a large excess of values in both the upper and
lower tails, compared with the more intuitive normal
distribution. Thus, it is not entirely unexpected to ob-
serve widely disparate LOD scores, even in the presence
of a consistent QTL. Since significant LOD scores are
only expected in a fraction of scans, even for significant
QTLs and relatively large data sets, careful interpreta-
tion of replication studies is required. Of course, the
presence of population-specific effects, should they exist,
would only add to the expected variability in LOD
scores.
We also pooled our data from the four populations,
using genome-search metaanalysis (GSMA; Wise et al.
1999). In this method, the genome is divided into ∼100
bins, and the bins are ranked according to LOD score
for each scan. The rankings are summed across scans,
and the P value for this summed ranking is calculated
for each bin. We applied GSMA to our four scans; con-
sistent with the wide variability in LOD scores we ob-
served, no region of the genome achieved significance
after correction for multiple hypothesis testing across
100 bins. The bin with the best rank sum overlapped
the 6q24-25 linkage peak observed in the Botnia pop-
ulation (nominal P value .01).
Study Design Considerations
The families we studied using linkage analysis were
not ascertained on the basis of extremes of adult height.
It is therefore possible that these studies are relatively
inefficient because families are included that contribute
little to the evidence for linkage. To explore this possi-
Table 2
Regions of Linkage with LOD Score 11.0
Chromosome and Markers Peak Marker(s) cM LOD Population
1:
D1S1665-D1S1665 D1S1665 98 1.01 Sweden
D1S210-D1S242 D1S210 189 1.35 Botnia
2:
D2S1790-D2S1399 D2S113 104 2.23 Botnia
D2S1391-D2S116 D2S364-D2S116 185 1.29 Botnia
3:
D3S1766-D3S1752 D3S1766 72 2.31 Finland
D3S1763-D3S2427 D3S3053 175 1.49 Botnia
D3S2436-D3S2398 D3S2398 204 1.19 Saguenay–Lac-St.-Jean
4:
D4S1614-D4S432 D4S1614 0 1.30 Botnia
D4S2366-D4S403 D4S403 13 1.26 Saguenay–Lac-St.-Jean
D4S1542-GATA4C04 D4S1564 108 2.28 Botnia
D4S1540-D4S426 D4S1540 193 1.73 Finland
D4S1554-D4S1652 D4S3051-D4S426 201 1.89 Botnia
5:
D5S395-D5S650 GATA67D03 60 1.75 Sweden
6:
D6S1574-D6S1574 D6S1574 8 1.08 Sweden
D6S462-D6S404 D6S1021 111 1.82 Botnia
D6S1003-D6S281 D6S1007 159 3.85 Botnia
7:
D7S1799-D7S2546 D7S2195 150 3.40 Sweden
8:
D8S258-D8S1477 D8S1752 46 1.31 Finland
D8S557-D8S373 D8S1100-D8S373 159 2.52 Finland
9:
D9S288-D9S175 D9S1868 42 2.01 Botnia
11:
D11S1984-D11S2362 D11S1984 0 1.47 Botnia
D11S1984-ATA34E08 D11S2362-D11S1999 11 2.57 Sweden
D11S905-FGF3 D11S1337 66 1.84 Botnia
12:
D12S341-D12S374 D12S341 0 2.07 Finland
D12S1042-D12S1072 D12S1090-D12S398 56 3.35 Finland
13:
D13S221-GGAA29H03 D13S221-GGAA29H03 13 1.01 Finland
D13S788-D13S285 D13S779-D13S797 80 3.56 Finland
15:
D15S816-D15S657 D15S816 94 1.33 Finland
17:
D17S974-D17S1293 D17S122 40 1.35 Saguenay–Lac-St.-Jean
D17S1294-D17S1290 D17S958 66 2.69 Botnia
18:
D18S68-D18S554 D18S541-D18S1121 111 1.58 Botnia
D18S55-D18S554 D18S1121 116 1.77 Finland
19:
D19S878-D19S1034 D19S878-D19S247 2 1.25 Sweden
20:
D20S471-D20S173 D20S96 56 2.51 Botnia
21:
D21S1437-D21S1437 D21S1437 0 1.04 Saguenay–Lac-St.-Jean
22:
D22S420-D22S686 D22S420 0 1.95 Sweden
D22S420-D22S283 D22S281 27 1.66 Botnia
D22S423-D22S1140 D22S282 44 1.10 Finland
NOTE.—For each population and chromosome, regions where the LOD score is 1.0 are listed,
as is the maximum LOD score, located within the region at the indicated peak marker(s) and
approximate distance in cM. Boxed pairs of rows indicate overlapping regions; boldface italic type
indicates regions with empiric genomewide P value !.05.
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Figure 3 Expected distribution of LOD scores in the presence of a modest QTL. 500 data sets with the pedigree structure of the Swedish
sample used in the study were generated under the assumption of an additive QTL explaining 20% of total variance. A histogram of the
percentage of the 500 simulated scans yielding different observed LOD scores is shown.
bility, we ordered the 58 Botnia families by total stature
variance to determine how many of the families were
responsible for the linkage to chromosome 6q. We per-
formed an ordered subset analysis by adding in families
10 at a time, ranked in increasing order of intrafamilial
variance, and repeating the variance-components anal-
ysis for chromosome 6. No subset of families provided
markedly disproportionate evidence for linkage (fig. 4),
indicating that selective ascertainment of families may
provide only modest gains in efficiency. A similar or-
dered-subset analysis of the Sweden sample for chro-
mosome 7 and the Finland sample for chromosomes 12
and 13 also revealed only modest gains in efficiency (data
not shown).
Discussion
Complex traits represent an important area of study for
human genetics. Studying highly heritable traits that can
be unambiguously phenotyped may advance our under-
standing of how to dissect the genetic architecture of
these traits. As an initial study, we analyzed data from
genomewide studies, involving 2,327 individuals from
four different populations, and found evidence for link-
age to stature in four chromosomal regions. This number
of positive results is unlikely to have occurred by chance,
as assessed by simulations, suggesting that at least some
of the regions represent regions of genuine linkage to
stature. Encouragingly, one of the regions (7q31.3-36)
showed strong suggestive evidence for linkage both in
our studies and in studies described in an accompanying
article (Perola et al. 2001 [in this issue]) and therefore
is likely to represent a region of true linkage.
One striking feature of our results is that the regions
with strongest evidence of linkage in a given study show
little evidence for linkage in most or all of the other
studies. This inconsistent pattern is similar to those seen
in studies of common diseases (e.g., Lernmark and Ott
1998; Lindgren and Hirschhorn 2001). Thus, under-
standing the source of this variation in linkage may have
significant implications for interpreting linkage studies
of common disease. For QTLs with modest genetic
effects, we have suggested that statistical fluctuation
caused by sampling variation may help explain appar-
ently inconsistent linkage results. Indeed, our simula-
tions suggest that a modest QTL (explaining 20% of
variance) could give a strong signal in one scan but be
essentially undetectable in other scans, simply on the
basis of sampling variation. Definitive interpretation of
one or a few negative replication studies, therefore, is
somewhat difficult. In addition, if multiple QTLs con-
tribute to a trait, it becomes likely that the genetic effect
will have been overestimated for the QTL with the best
LOD score (the “winner’s curse”). In this case, addi-
tional studies with large sample sizes may be required
to help clarify the evidence for linkage.
Although sampling variation in the presence of mod-
est QTLs may fully explain our data, there are other
possible reasons for the variable LOD scores we ob-
served. In theory, a causal genetic variant may be com-
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Table 3
Empirical P Values for Each Population
LOD Botnia Finland Sweden
Saguenay–
Lac-St.-Jean
2.5 .56 .31 .11 .05
2.6 .50 .27 .08 .05
2.7 .46 .25 .06 .05
2.8 .40 .20 .05 .04
2.9 .35 .18 .04 .03
3.0 .29 .12 .04 .02
3.1 .24 .11 .02 .02
3.2 .20 .08 .02 .01
3.3 .16 .05 .02 .01
3.4 .13 .05 .02 !.01
3.5 .11 .05 .02 !.01
3.6 .09 .05 .02 !.01
3.7 .07 .03 .02 !.01
3.8 .07 .02 .02 !.01
3.9 .05 .01 .02 !.01
NOTE.—P values were determined by performing
at least 100 simulations for each population, per-
muting genotypes under the hypothesis of no linkage.
For each LOD score, the reported P value is the frac-
tion of simulations in which that LOD score was ex-
ceeded in the indicated population.
Figure 4 Ordered subset analysis for linkage to chromosome 6,
ranking families by intrafamilial variance in stature. Families from
Botnia were ranked by total intrafamilial variance in height Z score,
and subsets of families were analyzed for linkage of stature to chro-
mosome 6. Subsets were successively increased in size by ∼10 families,
beginning with the families with the greatest variance. The % maxi-
mum LOD score (triangles) indicates the LOD score obtained using
the number of families indicated on the X-axis divided by the LOD
score obtained using the complete set; % of total individuals (circles)
is the fraction of the total population contained in the subset of families
being analyzed. The difference between the curves reflects the gain in
efficiency by considering only a subset of families.
mon in one population but rare in others (as might be
seen with founder effects, selection, or even genetic
drift), yielding very different linkage results. Similarly,
if the evidence for linkage reflects the combined effect
of two or more neighboring causal variants, population-
specific patterns of linkage disequilibrium between the
variants would result in fluctuating power to detect link-
age. It is interesting to note that, of the four populations
we studied, at least two are known to have founder
effects, which could affect allele frequencies and link-
age-disequilibrium relationships. It also remains a for-
mal possibility that a genetic variant present in all pop-
ulations is only functional in one or two, because of
interactions with population-specific genetic and or en-
vironmental factors. Finally, it is possible that our re-
sults represent statistical fluctuations or false positives
caused by an unknown artifact, despite results of sim-
ulations that suggest that the linkage peaks we observed
are unlikely to have occurred by chance. A definitive
understanding of the source of variability between stud-
ies is likely to require identification of causal variants
within implicated regions and examination of frequen-
cies and effects on height of the variants in each pop-
ulation. With improving technology and the potential
availability of large follow-up populations for linkage
disequilibrium mapping for stature, such studies are
now conceivable.
To our knowledge, the studies presented here and in
the accompanying article (Perola et al. 2001 [in this
issue]) represent the first reported genomewide studies
of stature. We did not see evidence of linkage to a pre-
viously reported region on chromosome 20 (Thompson
et al. 1995), but two of the most interesting regions
identified in this study (6q24-25 and 12p11.2-q14) are
centered on two of the genes previously reported to be
associated with variation in height (ESR1 and VDR;
Minamitani et al. 1998; Lorentzon et al. 1999). Al-
though initial studies of these genes did not reveal any
evidence of association in our populations (data not
shown), we have thus far tested only a few markers
around these genes. The availability of the genome se-
quence and an accompanying dense SNP map will en-
able more-exhaustive tests of these genes, and we are
currently engaged in these follow-up studies.
We have chosen to study stature as a model complex
genetic trait, but it is likely that other highly heritable,
easily phenotyped traits would be equally suitable.With
regard to the selection of such traits, it has been sug-
gested that normally distributed traits (such as stature)
should be avoided, since the presence of a major gene
will make the distribution deviate from normality (Al-
lison et al. 1999). However, trait values can still be
normally distributed, even in the presence of a single
locus explaining 150% of the total variance, particu-
larly if the segregating QTL is common in the popu-
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lation and has an additive effect (data not shown). Thus,
a normal or near-normal distribution should not ex-
clude a trait from being used in genetic studies.
Finally, the possibility of identifying a genetic variant
that affects final adult height raises important ethical
issues. Although such issues are relevant to most genetic
studies, the general public interest in height as a poten-
tial phenotype for genetic engineeringmakes these issues
particularly relevant in this context. For example, ge-
netic modification and/or selection of embryos to “de-
sign” taller (or shorter) offspring would be, in our view,
unethical, as well as fraught with possible unintended
secondary consequences. However, a greater under-
standing of the genetic basis of stature could have ap-
propriate and beneficial uses, including diagnosis, prog-
nosis, and possible reassurance for children with short
or tall stature, as well as contributing to a greater un-
derstanding of human biology and the genetic architec-
ture of complex traits.
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